During the recent session, Revelation Biosciences Inc (NASDAQ:REVB)’s traded shares were 1.42 million, with the beta value of the company hitting 0.09. At the last check today, the stock’s price was $0.96, reflecting an intraday loss of -50.19% or -$0.97. The 52-week high for the REVB share is $60.80, that puts it down -6233.33 from that peak though still a striking -97.92% loss since the share price plummeted to a 52-week low of $1.90. The company’s market capitalization is $0.93M, and the average trade volume was 117.10K shares over the past three months.

Revelation Biosciences Inc (REVB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. REVB has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -2.05.

Revelation Biosciences Inc (NASDAQ:REVB) trade information

Revelation Biosciences Inc (REVB) registered a -50.19% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -50.19% in intraday trading to $0.96, hitting a weekly high. The stock’s 5-day price performance is -62.52%, and it has moved by -67.61% in 30 days. Based on these gigs, the overall price performance for the year is -96.72%.

REVB Dividends

Revelation Biosciences Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of Revelation Biosciences Inc (REVB) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. Data provided on Mar 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 3.4 shares. This amounts to just over 0.35 percent of the company’s overall shares, with a $3131.0 market value. The same data shows that the other fund manager holds slightly less at 363.0, or about 0.04% of the stock, which is worth about $333.0.